Company intelligence / Profile preview
Myanma Pharmaceutical Industrial Enterprise
- Ownership
- Private
- Development stage
- Other
Overview
The company manufactures and distributes over 200 essential pharmaceutical products including antibiotics, vaccines, and antivenom, serving 3–10% of domestic market share and exporting antivenom to Cambodia and Laos; launched new vaccine and antibiotic product lines in recent years[1][3].
- Therapeutic areas
- Infectious DiseasesOther
- Modalities
- Small moleculeVaccineProteinAntibioticAntivenom
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Myanma Pharmaceutical Industrial Enterprise.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Myanma Pharmaceutical Industrial Enterprise.